02325 YUNKANG GROUP
- 11.040
- -0.060-0.54%
YUNKANG GROUP News
雲康集團：2023年度報告
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Read Yunkang Group (2325.HK)'s 2023 performance report in one picture
On March 25, Yunkang Group (2325.HK) announced its 2023 results announcement. In 2023, the company recorded revenue of 892 million yuan (RMB, same unit), an increase of 31.5% compared with 2019. As of December 31, 2023, Yunkang's customers spread across 31 provinces and autonomous regions, and more than 200 cities. It has built 416 medical consortium on-site diagnosis centers, 1,500+ medical and non-medical institutions, 3,900 medical and non-medical institutions, with more than 3,000 testing projects, and the company has more than 800 doctors and medical technicians. underneath
Yunkang Swings to Loss in 2023; Recommends Dividend
Yunkang Group (HKG:2325) recorded a net loss of 101.9 million yuan for the year ended December 2023, as opposed to a profit of 373.9 million yuan in the preceding year, according to a Monday filing wi
YUNKANG GROUP To Go Ex-Dividend On July 4th, 2024 With 0.02 HKD Dividend Per Share
March 26th - $YUNKANG GROUP(02325.HK)$ is trading ex-dividend on July 4th, 2024. Shareholders of record on July 5th, 2024 will receive 0.02 HKD dividend per share. The ex-dividend date is July 4th
Press Release: Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million
HONG KONG, March 25, 2024 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year ended December 31, 2023 (the "Reporting Period").
Yunkang Group (02325) will pay a final dividend of HK$0.02 per share
Yunkang Group (02325) announced that the company will distribute final shares for the year ended December 31, 2023...
Yunkang Group (02325) announced annual results. Shareholders' losses amounted to 102 million yuan year-on-year profit and loss
Yunkang Group (02325) announced its annual results for the year ended December 31, 2023. The group reaped benefits, people...
YUNKANG GROUP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Yunkang Group (02325.HK) held a board meeting on March 25 to approve annual results
Gelonghui, March 13, 丨 Yunkang Group (02325.HK) announced that the company will hold a board meeting on March 25, 2024 (Monday) to (among others) approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and consider payment of a final dividend (if any).
Yunkang Group Expects a Loss of Up to 130 Million Yuan for Full Year 2023
Yunkang Group (HKG:2325) expects a net loss of 90 million yuan to 130 million yuan for the year ended Dec. 31, 2023, compared with a net profit of 373.9 million yuan in the prior year, a Hong Kong bou
Yunkang Group (02325.HK) issued an announcement. The routine testing business achieved healthy and steady growth, and the net cash from operating activities improved markedly
Gelonghui, March 5, 丨 Yunkang Group (02325.HK) announced that the Group expects to record a net loss of between RMB 90 million and RMB 130 million for the year ended December 31, 2023, while a profit of RMB 373.9 million was recorded for the year ended 31 December 2022. The expected change in profit to loss is mainly due to: (i) During the reporting period, the Group's overall diagnostic service revenue declined significantly compared to the same period last year due to the decline in demand for phased testing and screening across the country, resulting in a decrease in the Group's profit. However, without considering the impact of the national phased testing and screening business, it was collected during the reporting period
YUNKANG GROUP: PROFIT WARNING
Should Weakness in Yunkang Group Limited's (HKG:2325) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Yunkang Group (HKG:2325) has had a rough three months with its share price down 6.6%. However, stock prices are usually driven by a company's financials over the long term, which in this case look p
Yunkang Group (02325) fell 5.00% and is now reported at 11.440 yuan, a 52-week low
As of 10:18, Yunkang Group (02325) was down 5.00% from yesterday's closing price. Currently, it was reported at $11.440, a 52-week low; trading volume was 31,500 shares, with a turnover of HK$3681,000.
Yunkang Group (02325) fell 2.40% and is now reported at 11.760 yuan, a 52-week low
As of 15:03 Yunkang Group (02325), down 2.40% from yesterday's closing price, is now reported at $11.760, a 52-week low; the turnover volume is 88,000 shares, with a turnover of HK$1,043,000.
Yunkang Group appoints China Audit Zhonghuan as auditor
Yunkang Group (02325) announced that since CIC Zhonghuan has completed the customer acceptance process and has officially signed an appointment letter to the company dated November 23, 2023, the board of directors has appointed CIC Zhonghuan as an auditor in accordance with the recommendations of the Audit Committee, effective November 23, 2023, to fill the temporary vacancies after the resignation of PricewaterhouseCoopers and will serve until the end of the company's next Annual General Meeting of Shareholders.
YUNKANG GROUP: 2023 INTERIM REPORT
Yunkang Group (02325.HK) announced its interim results: revenue reached 477 million yuan, cash and cash equivalents increased to 1,269 million yuan, and the main waterway business is developing steadily
Glonghui, August 30, 丨 Yunkang Group (02325.HK) announced its interim results. In the six months ended June 30, 2023, the company achieved revenue of 477 million yuan, gross profit of RMB 182 million, gross margin of 38.1%. Profit attributable to company owners was RMB 487.15 million, and a net profit margin of 10.1%. On June 30, 2023, the Group's cash and cash equivalents increased from RMB 788 million on December 31, 2022 to RMB 1,269 million, mainly due to an increase in net cash from operating activities and net cash from investment activities
YUNKANG GROUP: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Analysis
Price Target
No Data
